BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 38504345)

  • 1. Loss of mutL homolog-1 (MLH1) expression promotes acquisition of oncogenic and inhibitor-resistant point mutations in tyrosine kinases.
    Springuel L; Losdyck E; Saussoy P; Turcq B; Mahon FX; Knoops L; Renauld JC
    Cell Mol Life Sci; 2016 Dec; 73(24):4739-4748. PubMed ID: 27436342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of chemically induced rodent models for sporadic colorectal cancer: Histopathological and translational perspectives.
    Sarmiento-Machado LM; Rodrigues MAM; Romualdo GR; Barbisan LF
    Histol Histopathol; 2024 Jun; 39(6):691-702. PubMed ID: 38179656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microsatellite instability: an update.
    Yamamoto H; Imai K
    Arch Toxicol; 2015 Jun; 89(6):899-921. PubMed ID: 25701956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic MLH1 silencing concurs with mismatch repair deficiency in sporadic, naturally occurring colorectal cancer in rhesus macaques.
    Deycmar S; Johnson BJ; Ray K; Schaaf GW; Ryan DP; Cullin C; Dozier BL; Ferguson B; Bimber BN; Olson JD; Caudell DL; Whitlow CT; Solingapuram Sai KK; Romero EC; Villinger FJ; Burgos AG; Ainsworth HC; Miller LD; Hawkins GA; Chou JW; Gomes B; Hettich M; Ceppi M; Charo J; Cline JM
    J Transl Med; 2024 Mar; 22(1):292. PubMed ID: 38504345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative molecular genomic analyses of a spontaneous rhesus macaque model of mismatch repair-deficient colorectal cancer.
    Ozirmak Lermi N; Gray SB; Bowen CM; Reyes-Uribe L; Dray BK; Deng N; Harris RA; Raveendran M; Benavides F; Hodo CL; Taggart MW; Colbert Maresso K; Sinha KM; Rogers J; Vilar E
    PLoS Genet; 2022 Apr; 18(4):e1010163. PubMed ID: 35446842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of mismatch-repair/microsatellite instability-discordant endometrial cancers.
    Riedinger CJ; Esnakula A; Haight PJ; Suarez AA; Chen W; Gillespie J; Villacres A; Chassen A; Cohn DE; Goodfellow PJ; Cosgrove CM
    Cancer; 2024 Feb; 130(3):385-399. PubMed ID: 37751191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in genetic technologies result in improved diagnosis of mismatch repair deficiency in colorectal and endometrial cancers.
    Evans DG; Lalloo F; Ryan NA; Bowers N; Green K; Woodward ER; Clancy T; Bolton J; McVey RJ; Wallace AJ; Newton K; Hill J; McMahon R; Crosbie EJ
    J Med Genet; 2022 Apr; 59(4):328-334. PubMed ID: 33452216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double somatic mutations in mismatch repair genes are frequent in colorectal cancer after Hodgkin's lymphoma treatment.
    Rigter LS; Snaebjornsson P; Rosenberg EH; Atmodimedjo PN; Aleman BM; Ten Hoeve J; Geurts-Giele WR; ; van Ravesteyn TW; Hoeksel J; Meijer GA; Te Riele H; van Leeuwen FE; Dinjens WN; van Leerdam ME
    Gut; 2018 Mar; 67(3):447-455. PubMed ID: 29439113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical detection of ARID1A in colorectal carcinoma: loss of staining is associated with sporadic microsatellite unstable tumors with medullary histology and high TNM stage.
    Ye J; Zhou Y; Weiser MR; Gönen M; Zhang L; Samdani T; Bacares R; DeLair D; Ivelja S; Vakiani E; Klimstra DS; Soslow RA; Shia J
    Hum Pathol; 2014 Dec; 45(12):2430-6. PubMed ID: 25311944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRD4 inhibition impairs DNA mismatch repair, induces mismatch repair mutation signatures and creates therapeutic vulnerability to immune checkpoint blockade in MMR-proficient tumors.
    Fu Y; Yang B; Cui Y; Hu X; Li X; Lu F; Qin T; Zhang L; Hu Z; Guo E; Fan J; Xiao R; Li W; Qin X; Hu D; Peng W; Liu J; Wang B; Mills GB; Chen G; Sun C
    J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37072347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous, naturally occurring cancers in non-human primates as a translational model for cancer immunotherapy.
    Deycmar S; Gomes B; Charo J; Ceppi M; Cline JM
    J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36593067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inducing mismatch repair deficiency sensitizes immune-cold neuroblastoma to anti-CTLA4 and generates broad anti-tumor immune memory.
    El-Hajjar M; Gerhardt L; Hong MMY; Krishnamoorthy M; Figueredo R; Zheng X; Koropatnick J; Maleki Vareki S
    Mol Ther; 2023 Feb; 31(2):535-551. PubMed ID: 36068918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Routine Immunohistochemical Analysis of Mismatch Repair Proteins in Colorectal Cancer-A Prospective Analysis.
    Lemos Garcia J; Rosa I; Saraiva S; Marques I; Fonseca R; Lage P; Francisco I; Silva P; Filipe B; Albuquerque C; Claro I
    Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35954394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of TP53 and CDKN2A Mutation Profile with Tumor Mutation Burden in Head and Neck Cancer.
    Deneka AY; Baca Y; Serebriiskii IG; Nicolas E; Parker MI; Nguyen TT; Xiu J; Korn WM; Demeure MJ; Wise-Draper T; Sukari A; Burtness B; Golemis EA
    Clin Cancer Res; 2022 May; 28(9):1925-1937. PubMed ID: 35491653
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.